Background: The 650-ms, 1064-nm Nd:YAG laser device may provide superior efficacy and tolerability for the treatment of acne vulgaris over conventional treatments.
Aim: To evaluate the efficacy and tolerability of a 650-ms laser for the treatment of mild to severe facial acne vulgaris.
Patients/methods: Records of 225 subjects with mild to severe facial acne vulgaris and treated with a 650-ms laser were reviewed.
Results: Subjects required a median of 3 treatments to achieve clearance. Clearance was achieved in 108/225 (48%) subjects. Adverse effects were limited to acne flare-ups and dryness. Treatment with isotretinoin was not required in 180/209 (80%) of subjects. A variety of topical and oral medications and non-laser procedures may be used in conjunction with the 650-ms laser without adverse effects. At the 6-month follow-up visit, the median Investigator Global Scale (IGA) score was 1.0 (almost clear). For most IGA-rated parameters differences between white patients and patients with skin of color were not statistically significant.
Conclusion: The 650-ms, 1064-nm Nd:YAG laser provides a safe and efficacious treatment of mild to severe acne in patients with white skin and skin of color.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/jocd.16711 | DOI Listing |
Photodiagnosis Photodyn Ther
December 2024
Department of Dermatology, Shenzhen People's Hospital (The Second Clinical Medical College of Jinan University; The First Affiliated Hospital of Southern University of Science and Technology), Shenzhen 518020, Guangdong, China; Candidate Branch of National Clinical Research Center for Skin Diseases, Shenzhen 518020, Guangdong, China. Electronic address:
Background: ALA-PDT has been widely used in mild to moderate acne vulgaris worldwide. However, very few studies used riboflavin-PDT to treat acne vulgaris.
Objective: To investigate the efficacy and adverse events of riboflavin-PDT to treat mild to moderate facial acne, and compare it with ALA-PDT on a non-inferiority basis.
Post acne erythema (PAE) is a common sequela of acne inflammation, and it refers to telangiectasia and erythematous lesions remaining after the acne treatment. Although some PAE may improve over time, persisting PAE might be esthetically undesirable for patients. The efficacy of various treatment options for PAE has been investigated in many studies but there exists no gold standard treatment modality.
View Article and Find Full Text PDFBackground And Aims: Metformin is a widely used oral agent for controlling diabetes mellitus, but it also has other therapeutic benefits for various conditions. In addition, conventional oral metformin, and topical metformin have been used in, in-vitro studies in the treatment of acne, psoriasis, wound healing, and and so forth. While topical metformin has shown promising results in animal studies, there is limited data on its effectiveness in humans.
View Article and Find Full Text PDFBMJ Case Rep
December 2024
Division of Infectious Diseases, Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA.
Antibiotics are indicated for inappropriately prolonged durations not only for infectious diseases but also for non-infectious dermatologic conditions such as acne vulgaris, but inappropriate use is not uncommon. Inappropriate antibiotic prescription can contribute to the emergence of multidrug-resistant organisms, patient harm such as adverse drug events and increased healthcare costs. We experienced a case involving a late adolescent with acne vulgaris who had been treated with minocycline for more than 2 years, leading to the development of drug-induced lupus, attributed to minocycline.
View Article and Find Full Text PDFJ Cosmet Dermatol
December 2024
Department of Dermatology and Venereology, Gulhane Medical Faculty, University of Health Sciences, Ankara, Turkey.
Background: Acne vulgaris, a common dermatological condition, has physical manifestations and significant emotional and social implications for those affected. This study aims to assess the stigma experienced by acne vulgaris patients and identify relevant physical, social, and psychological factors.
Methods: The research involved individuals aged 12-45 diagnosed with acne vulgaris.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!